Our results might suggest that plant miRNAs could attenuate fat deposition by inhibiting lipid-metabolism specific transcription factors (SREBF1), as previously suggested for other plant bioactive compounds (such as resveratrol), and thus could be applied for the treatment of NAFLD [58]. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.